Advertisement

Topics

J&J To Get EU Fast-Track Decision On Apalutamide

07:24 EST 24 Jan 2018 | Elsevier Business Intelligence

J&J is hoping EU regulators will follow the US in fast-tracking the company’s prostate cancer franchise-extending drug ...

Original Article: J&J To Get EU Fast-Track Decision On Apalutamide

NEXT ARTICLE

More From BioPortfolio on "J&J To Get EU Fast-Track Decision On Apalutamide"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...